LIVE TV
ZEE Business
ZEE BUSINESS
हिंदी में पढ़ें  हिंदी में पढ़ें
Live TV
Live TV
  • Home
  • Budget 2021
  • Personal Finance
    • PPF
    • Mutual Funds
    • Income tax
    • EPFO
    • Income Tax Calculator
    • Personal Loan Calculator
    • Car Loan Calculator
    • Home Loan Calculator
    • SIP calculator
    • SWP Calculator
    • MF Returns Calculator
    • Lumpsum Calculator
  • India
    • Companies
    • Property
    • Startups
    • Uidai
  • Economy
    • Aviation
  • Tech
    • Mobiles
    • Apps
  • Auto
    • Cars
    • Bikes
  • Markets
    • Commodities
    • Currency
  • Jobs
  • Indian Railways
  • World
    • Economy
    • Politics
    • Markets
  • videos
  • photos
  • Authors
  • More ...
    • VIDEOS
    • PHOTOS

Read in App
Business News » India News

Glenmark expects generics to drive growth over next 3 yrs

  • Twitter
  • Facebook
  • Linkedin
  • whatapp
  • View in App
Updated: Sun, Sep 24, 2017
03:19 pm
PTI
RELATED NEWS
Expert Views: BIG! India's retail inflation eases to 4.59% in December Expert Views: BIG! India's retail inflation eases to 4.59% in December
Budget 2021 Expectations – HOME BUYERS to benefit if Govt accepts this demand; JLL CEO lists following demands Budget 2021 Expectations – HOME BUYERS to benefit if Govt accepts this demand; JLL CEO lists following demands
Jobs, land prices, Covid-19 vaccine, rural India, household savings, NBFCs, banks, consumption, capex - Positives and Negatives | EXPLAINED Jobs, land prices, Covid-19 vaccine, rural India, household savings, NBFCs, banks, consumption, capex - Positives and Negatives | EXPLAINED
Economy, markets, FIIs, chemicals, IT and Pharma - Make money, as India powers to new highs | EXPLAINED    Economy, markets, FIIs, chemicals, IT and Pharma - Make money, as India powers to new highs | EXPLAINED
Setback for China – Trend reversing in favour of India; SFI lands big blow! Know here WHY! Setback for China – Trend reversing in favour of India; SFI lands big blow! Know here WHY!

Pharma firm Glenmark Pharmaceuticals has said its pipeline of specialty and innovative products over the next three to four years is expected to act as a defence against generics price erosion and competition, and will boost profitable growth.

Over the last few years the company has invested significantly to mark the step-wise transition from generics to an innovation-driven organisation, according to the company's annual report.

"Our pipeline of specialty products, to be rolled out over the next three to four years, is expected to act as a defence against generics price erosion and increase in competition, and boost profitable growth," Glenmark chairman and managing director Glenn Saldanha said.

"Over the next three years, generics will continue to fuel our growth. After that we expect the unlocking of revenues from the specialty/innovation business." The next few years will see consistent revenues and profitability without the need for inorganic growth through acquisitions, Saldanha said, adding that specialty and innovative products will comprise 30 per cent of its revenues by 2025.

"Growth will not come at the cost of profits. We anticipate steadily improving our profitability margin from 22 per cent - 25 per cent by 2025. Our R&D expenses will stay at roughly 11 - 12 per cent of revenues," he said.

The company said that its focus in emerging markets will be to invest in product pipeline in dermatology, respiratory and the oncology therapy and focus on discovering primarily first-in-class molecules globally.

"Despite the challenging economic situation in most emerging markets including the volatile currencies, we will continue to remain positive on the long-term growth prospects in key emerging markets," the company said.

The US market will continue to remain the most important market and it will continue to invest significantly, it said.

All the incremental R&D resources are being invested in the US market and this region will be a key driver for growth in the future.

The company will also continue with its approach of out-licensing its molecules, the annual report said. Going ahead, the organisation will continue to lay equal emphasis on small molecules as well as biologics and will continue to focus on discovering primarily first-in-class molecules globally for unmet medical needs.

 

(This article has not been edited by Zeebiz editorial team and is auto-generated from an agency feed.)

Get Latest Business News, Stock Market Updates and Videos; Check your tax outgo through Income Tax Calculator and save money through our Personal Finance coverage. Check Business Breaking News Live on Zee Business Twitter and Facebook. Subscribe on YouTube.

TAGS:
Economy
RELATED NEWS
Expert Views: BIG! India's retail inflation eases to 4.59% in December Expert Views: BIG! India's retail inflation eases to 4.59% in December
Budget 2021 Expectations – HOME BUYERS to benefit if Govt accepts this demand; JLL CEO lists following demands Budget 2021 Expectations – HOME BUYERS to benefit if Govt accepts this demand; JLL CEO lists following demands
Jobs, land prices, Covid-19 vaccine, rural India, household savings, NBFCs, banks, consumption, capex - Positives and Negatives | EXPLAINED Jobs, land prices, Covid-19 vaccine, rural India, household savings, NBFCs, banks, consumption, capex - Positives and Negatives | EXPLAINED
Economy, markets, FIIs, chemicals, IT and Pharma - Make money, as India powers to new highs | EXPLAINED    Economy, markets, FIIs, chemicals, IT and Pharma - Make money, as India powers to new highs | EXPLAINED
Setback for China – Trend reversing in favour of India; SFI lands big blow! Know here WHY! Setback for China – Trend reversing in favour of India; SFI lands big blow! Know here WHY!

LATEST NEWS

Stocks to buy with Anil Singhvi: Sanjiv Bhasin bullish on HCL Tech and ICICI Prudential Life

Anil Singhvi’s Strategy January 27: Day support zone on Nifty is 14,125-14,150 & Bank Nifty is 30,900-31,000

This trick will grow your money much better | Mutual Fund Sahi Hai - Varun Sridhar, Manikaran Singhal EXPLAIN how to get rich faster

Microsoft surpasses $5B in gaming revenue for 1st time: Satya Nadella

Homefirst Finance IPO Share Allotment Status: Here is how to check subscription - Step by step guide

Delhi Metro News: Big decision by DMRC! No entry, exit on these stations; see full list, know reason

Income Tax Holiday: Realtors demand extension for affordable housing projects from FM Nirmala Sitharaman

Jayalalithaa memorial inaugurated in Tamil Nadu by CM

Triumph unveils all-new Speed Triple 1200 RS; See complete features here!

''Nancy Drew'' spinoff ''Tom Swift'' casts Tian Richards in lead role

  • India News
  • World News
  • Companies News
  • Market News
  • Personal Finance News
  • Technology News
  • Automobile News
  • Small Business News
  • Income Tax Calculator
  • Live TV
  • Videos
  • Photos
  • Author
  • Rss Feed
  • Advertise with us
  • Privacy Policy
  • Legal Disclaimer

Latest Trending Updates

  • EPFO
  • Budget 2020
  • Income Tax Return
  • Auto Expo 2020
  • Home Loan
  • Business News

Trending Topics

  • Income Tax
  • income Tax Calculator
  • 7th Pay Commission
  • Reserve Bank of India
  • GST
  • Latest Business News

Follow us on

zeebiz
zeebiz

Partner Sites

  • Zee News
  • Hindi News
  • Marathi News
  • Bengali News
  • Tamil News
  • Malayalam News
  • Gujarati News
  • Telugu News
  • Kannada News
  • DNA
  • WION
Copyright © Zee Media Corporation Ltd. All rights reserved